Disclosing adverse events in clinical practice: the delicate act of being open

BJ Myren, JA de Hullu, S Bastiaans… - Health …, 2022 - Taylor & Francis
Practicing a “safe” disclosure of adverse events remains challenging for healthcare
professionals. In addition, knowledge on how to deliver a disclosure is still limited. This …

[HTML][HTML] Openness to new perspectives created by patient participation at the morbidity and mortality meeting

BJ Myren, RPMG Hermens, JJ Koksma… - Patient Education and …, 2021 - Elsevier
Objectives Morbidity and mortality meetings (M&MMs) at surgical departments may improve
when patients participate, leading to different learning points. A gynecological oncology …

[HTML][HTML] Patient participation at the morbidity and mortality meeting: a transformative learning experience

BJ Myren, PLM Zusterzeel, JA De Hullu… - … -Qualitative Research in …, 2022 - Elsevier
Purpose Implementing a patient-centered innovation is a complex process that requires
commitment and attention from the healthcare professionals and organizations involved …

[HTML][HTML] Cyclic workflow to improve implementation of learning points from morbidity and mortality meetings

BJ Myren, JA de Hullu, JJ Koksma… - BMC Health Services …, 2022 - Springer
Background Morbidity and mortality meetings (M&MMs) are organized in most hospital
departments with an educational purpose to learn from adverse events (AEs) to improve …

Development of a decision aid for primary treatment of patients with advanced-stage ovarian cancer

JE den Ouden, BJ Myren, D Boll… - International Journal of …, 2020 - ijgc.bmj.com
Introduction Despite renewed treatment options for advanced epithelial ovarian cancer,
survival remains poor. The Patient Association and the Gynecological Oncology Working …